Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets by Vester, Birte et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Molecular Biology
Open Access Research article
Locked nucleoside analogues expand the potential of DNAzymes to 
cleave structured RNA targets
Birte Vester*1, Lykke H Hansen1, Lars Bo Lundberg1, B Ravindra Babu2, 
Mads D Sørensen3, Jesper Wengel2 and Stephen Douthwaite1
Address: 1The Nucleic Acid Center, Department of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5230 Odense M, 
Denmark, 2The Nucleic Acid Center, Department of Chemistry, University of Southern Denmark, DK-5230 Odense M, Denmark and 3Department 
of Chemistry, University of Copenhagen, Universitetsparken 5, DK-2100 Copenhagen, Denmark
Email: Birte Vester* - b.vester@bmb.sdu.dk; Lykke H Hansen - lhh@bmb.sdu.dk; Lars Bo Lundberg - lundberg_larsbo@msn.com; B 
Ravindra Babu - ravi.babu@leo-pharma.com; Mads D Sørensen - mds@crc.dk; Jesper Wengel - jwe@chem.sdu.dk; 
Stephen Douthwaite - srd@bmb.sdu.dk
* Corresponding author    
Abstract
Background: DNAzymes cleave at predetermined sequences within RNA. A prerequisite for
cleavage is that the DNAzyme can gain access to its target, and thus the DNAzyme must be capable
of unfolding higher-order structures that are present in the RNA substrate. However, in many
cases the RNA target sequence is hidden in a region that is too tightly structured to be accessed
under physiological conditions by DNAzymes.
Results:  We investigated how incorporation of LNA (locked nucleic acid) monomers into
DNAzymes improves their ability to gain access and cleave at highly-structured RNA targets. The
binding arms of DNAzymes were varied in length and were substituted with up to three LNA and
α-L-LNA monomers (forming LNAzymes). For one DNAzyme, the overall cleavage reaction
proceeded fifty times faster after incorporation of two α-L-LNA monomers per binding arm (kobs
increased from 0.014 min-1 to 0.78 min-1).
Conclusion: The data demonstrate how hydrolytic performance can be enhanced by design of
LNAzymes, and indicate that there are optimal lengths for the binding arms and for the number of
modified LNA monomers.
Background
DNAzymes function as specific endonucleases by binding
to predetermined sequences in RNA and cleaving its phos-
phodiester backbone. The discovery that RNA-hydrolytic
properties could be encoded within a DNA oligonucle-
otide indicated potential biotechnological applications in
gene silencing. These applications might even surpass
those of other oligonucleotide-based gene silencing
approaches, such as antisense and RNAi technologies, that
require the complicity of the cell's own nuclease systems
in order to cleave RNA. However, the use of DNAzymes
has been restricted by several limitations, some of which
are shared with the other oligonucleotide-based technol-
ogies. For any of these approaches to be of value, the oli-
gonucleotide must be capable of transversing the cellular
membrane and avoid being inactivated by cellular nucle-
ases long enough to find the appropriate cellular compart-
ment where it can bind and induce cleavage at the target
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RNA. Modification of DNAzymes to improve their stabil-
ity against cellular nucleases and their ability to bind and
cleave RNA molecules would go a long way towards
increasing their general applicability.
The 10–23 DNAzyme isolated by Santoro and Joyce [1]
(Fig. 1A) provides a suitable starting point for such modi-
fication and improvement. DNAzymes of this type cleave
purine-uracil targets, and to a lesser extent purine-cytosine
targets, and have been subjected to numerous investiga-
tions to alter target preference [2], to follow the folding of
the catalytic region [3], and to induce cleavage at different
targets [4,5]. Quite conclusive is that most DNAzymes of
this type fail to cleave their RNA targets in vitro [4,5], and
this does not bode well for in vivo application with the
additional complications of cellular nucleases and sub-
strate compartmentalization. Poor cleavage in vitro is gen-
erally linked to the inability of a DNAzyme to recognize
its target, which involves unravelling the higher-order
structure of the RNA and hybridizing via the two binding
arms of the DNAzyme (Fig. 1). The binding arms can be
constructed to include modified nucleosides, and such
modifications have improved resistance against cellular
nucleases [6-10]. In principle, the inclusion of modified
nucleosides at specific sites in the binding arms could also
greatly enhance the hybridization potential of DNAzymes
at their RNA targets.
Modified nucleosides in the form of conformationally
locked analogues (Locked Nucleic Acid, LNA) are capable
of targeting complementary RNA and DNA with high
affinity [11,12], and are thus potentially interesting as
components in DNAzymes. Two commercially available
variants of these modified nucleosides (LNA and α-L-
LNA, Fig. 1B) can be incorporated into oligonucleotides
to increase their hybridization capacity [13-15]. Recent
reports [10,16-19] have shown that inclusion of LNA
monomers into the binding arms of DNAzymes (forming
what we term LNAzymes) enables structured RNA targets
to be cleaved, even in cases where the targets are intracta-
ble to unmodified DNAzymes. These studies indicate that
the potential of LNAzymes might be optimized by
rational design to cleave at targets that are located in
highly structured RNA substrates.
Here, we have conducted a systematic approach geared
towards the rational design of LNAzymes based on the
10–23 DNAzyme structure. Targets were displayed in RNA
substrates with progressively more stable structures to
challenge the cleavage capacity of DNAzymes. The ability
of the DNAzymes to unravel the RNA structures was inves-
tigated by varying the lengths and the modification con-
tent of the hybridization arms. RNA substrates that are
essentially inaccessible to unmodified DNAzymes were
cleaved with markedly higher efficiency when LNA or α-L-
LNA monomers were incorporated into the binding arms.
For each RNA target, there appear to be optima for lengths
of the binding arms, as well as for the type and number of
modifications they contain. While the improved ability of
LNAzymes to gain access to structured targets is the main
reason for their greater capacity to cleave RNAs, the mod-
ifications also appear to favourably affect other kinetic
parameters.
Results
RNA substrates for cleavage
RNA substrates contain two consecutive sequences that
are complementary to the binding arms of the DNAzymes
and bracket the cleavage site between a purine and a pyri-
midine (Fig. 1A). The cleavage sites studied here are dis-
played in RNA substrates that are based on sequences
from the Escherichia coli 23S ribosomal RNA, and possess
a range of structural complexity (Fig. 2). The substrates
consist of a 17n minimal RNA (largely unstructured), a
33n with metastable secondary structure, 58n and 74n
RNAs with stable secondary structures, and a 2904n RNA
(the intact E. coli 23S rRNA) with extensive secondary and
tertiary structure. Within these RNA substrates, three
A. Schematic of a 10–23 DNAzyme hybridized via Watson- Crick base-pairing to an RNA substrate Figure 1
A. Schematic of a 10–23 DNAzyme hybridized via Watson-
Crick base-pairing to an RNA substrate. The underlined 
sequence indicates the region where the LNA-type mono-
mers were introduced (Table 1). Pu, purine; Py, pyrimidine. 
B. Structures of LNA (locked nucleic acid) and α-L-LNA 
nucleoside monomers.BMC Molecular Biology 2006, 7:19 http://www.biomedcentral.com/1471-2199/7/19
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RNA substrates for LNA- and DNAzyme cleavage Figure 2
RNA substrates for LNA- and DNAzyme cleavage. RNA substrates for LNA- and DNAzyme cleavage. (A) 17n minimal 
RNA substrate; a 33n RNA with metastable secondary structure; and 58n and 74n RNAs that fold into well-defined secondary 
structures. Cleavage sites for the nucleic acid enzymes at nucleotides 745, 1093 and 1096 are shown by the arrows. The stem-
loop secondary structures containing the cleavage targets have been verified by numerous techniques including biochemical 
probing [28], NMR [29] and crystallography [30-32]. (B) Secondary structure of domain II of 23S RNA (2904n RNA), which 
contains all three cleavage sites. (C) Higher-order folding of the rRNA (2904n) within the 50S ribosomal subunit; all the stem-
loops in the smaller RNAs used here are maintained in the 2904n RNA (refs, PDB 1JJ2, [33]).BMC Molecular Biology 2006, 7:19 http://www.biomedcentral.com/1471-2199/7/19
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cleavage sites were studied: the 745-site (in the 74n and
2904n RNAs); the 1093-site (in the 17n, 33n, 58n and
2904n RNAs); and the 1096-site (in the 33n, 58n and
2904n RNAs).
DNAzymes and LNAzymes
The nucleic acid enzymes used in this study range from
unmodified DNAzymes to LNAzymes containing up to
three LNA or α-L-LNA monomers per binding arm (Table
1). The lengths of the binding arms were also varied from
five up to eight nucleotides; the catalytic loop remained
unchanged in all the enzymes. A single DNAzyme and
two LNAzymes were designed against the 745-site; one
DNAzyme and one LNAzyme were made to cleave the
1096-site. The cleavage site at 1093 was studied most sys-
tematically, and two DNAzymes plus five LNAzymes were
designed against this target. In the initial tests, the nucleic
acid enzymes were used in molar excess relative to the
RNA substrates, enabling us to study their performances
under single-turnover conditions. The kinetic parameters
of the most effective enzymes were then studied under
multiple-turnover conditions with an excess of substrate.
Cleavage at the 1093-site
Cleavage at the 1093-site in the 17n, 33n, 58n and 2904n
RNAs was carried out under single-turnover conditions
with a 5- to 50-fold excess of DNAzyme or LNAzyme (Fig.
3). The unstructured 17n RNA substrate was efficiently
cleaved by the unmodified DNAzyme (Dz1-1093), and
also by the corresponding LNAzymes with arms of eight
nucleotides (Lz1-1093, Lz2-1093 and Lz5-1093) (Fig.
3A). However, when the 1093-site was displayed in the
more tightly structured 58n RNA distinct differences were
seen: cleavage by the unmodified DNAzyme was only
marginal even at high concentration, whereas the
LNAzymes still cut as effectively as in the 17n RNA (Fig.
3B). This picture was intensified in the more highly struc-
tured 2904n RNA, which the DNAzyme Dz1-1093 failed
to cleave, whereas Lz1-1093 and Lz2-1093 still cut the
1093-site effectively (Fig. 3D). Incorporation of addi-
tional α-L-LNA modifications in Lz5-1093 resulted in less
cleavage of 2904n RNA than with Lz1-1093 (Fig. 3D).
Upon reduction of the length of the binding arms to five
and six nucleotides, the unmodified DNAzyme (Dz2-
1093) lost all measurable hydrolytic activity and, even in
large molar excess, was unable to cleave the minimal 17n
substrate (Fig. 3A). The shorter arm size was counteracted
to some extent by incorporating two α-L-LNA monomers
into each arm (in Lz4-1093), resulting in good cleavage of
17n and moderate cleavage of 58n RNA (Fig. 3B). Further
reduction of both arms to four nucleotides led to further
loss of activity, and at 50-fold excess the LNAzyme Lz3-
1093 could only weakly cut the 17n substrate despite hav-
ing two α-L-LNA monomers per binding arm.
Cleavage at the 745- and 1096-sites
These two additional cleavage sites were investigated to
establish whether the observations made for the 1093-site
could be extrapolated to other RNA targets. The 1096-site
is particularly interesting in this context as it is located
only three nucleotides away from the 1093-site and can
thus be displayed in the same hairpin loop of the RNA
substrates (Fig. 2). Despite this, the 1096-site proved
more difficult to cleave. The DNAzyme Dz3-1096 failed to
cut even when the 1096 target was presented in the rela-
tively unstructured 33n RNA (and consequently also
failed to cut the more complexly structured substrates,
such as 58n RNA in Fig. 3B). Modifying the binding arms
with two LNA monomers to form the LNAzyme Lz6-1096
Table 1: DNAzyme and LNAzyme sequences and their RNA substrates. The catalytic sequence (loop) is invariable in all the nucleic 
acid enzyme constructions and has the sequence 5'-GGCTAGCTACAACGA. RNA modifications in the hybridization arms are 
indicated by bold underlined nucleotides; the cytidine LNA residue in Lz6-1096 is methylated at the 5-position of the base. The RNA 
substrates that were cleaved by the respective enzymes are underlined, those that could not be cleaved are italicized (the 
enzyme:substrate ratios for cleavage are defined in Fig. 3).
Enzyme code Sequence (5' to 3') Type of modification RNA substrates 
(cleaveduncleaved)
Dz4-745 TTTTTCAA loop ATTAGTCG none 74n, 2904n
Lz7-745 TTTTTCAA loop ATTAGTCG α-L-LNA 74n, 2904n
Lz8-745 TTTTTCAA loop ATTAGTCG LNA 74n, 2904n
Dz1-1093 AGCTATTA loop GCTTTCTT none 17n, 33n, 58n,2904n
Lz1-1093 AGCTATTA loop GCTTTCTT α-L-LNA 17n, 58n, 2904n
Lz2-1093 AGCTATTA loop GCTTTCTT LNA 17n, 58n, 2904n
Lz5-1093 AGCTATTA loop GCTTTCTT α-L-LNA 58n, 2904n
Dz2-1093 TATTA loop GCTTTC none 17n, 2904n
Lz4-1093 TATTA loop GCTTTC α-L-LNA 17n, 58n, 2904n
Lz3-1093 ATTA loop GCTT α-L-LNA 17n, 58n, 2904n
Dz3-1096 GTGAGCTA loop TACGCTTT none 33n, 58n
Lz6-1096 GTGAGCTA loop TACGCTTT LNA 33n, 58nBMC Molecular Biology 2006, 7:19 http://www.biomedcentral.com/1471-2199/7/19
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led to effective cleavage at the 1096-site in the 33n and
58n RNA substrates (Fig. 3B).
The 745-site was also resilient to cleavage, and the
unmodified DNAzyme Dz4-745 was incapable of cutting
this target in either the 74n (Fig. 3C) or the 2904n RNAs
(Fig. 3E). Some cleavage was achieved by modifying the
enzyme to include two α-L-LNA monomers (Lz7-745) or
two LNA monomers per binding arm (Lz8-745), but
remained incomplete at 50-fold molar excess of the
enzymes. The LNAzyme with LNA monomers was mar-
ginally, but consistently, better at cleaving the RNA sub-
strates than its counterpart containing α-L-LNA.
Kinetic parameters for cleavage at the 1093-site
The two LNAzymes Lz1-1093 and Lz2-1093 performed
almost identically under single turnover conditions; this
is illustrated in Figs. 4A and 4B and is consistent with a
previous report [16]. The rate constant (kobs) for the
unmodified Dz1-1093 and the LNAzyme Lz1-1093 was
determined by fitting the time-course data for cleavage of
the 17n RNA (Fig. 4A) into an exponential curve. This
gave a kobs of 0.014 min-1 for the Dz1-1093 and a kobs of
0.78 min-1 for the Lz1-1093, showing that the overall reac-
tion proceeded fifty times faster for the LNAzyme. It
should be noted, however, that whereas the Dz1-1093
data fit comfortably into the exponential curve, the Lz1-
Gel analysis of LNA- and DNAzyme cleavage of RNA substrates under single-turnover conditions Figure 3
Gel analysis of LNA- and DNAzyme cleavage of RNA substrates under single-turnover conditions. The 
uncleaved RNAs substrates (filled arrows) and the cleavage products after one hour (unfilled arrows) are shown for a range of 
enzyme concentration (molar excess of enzyme in parentheses). No enzymes were added to the control sample, which were 
analyzed before (control 1) or after incubation (control 2). In A and B, the 17n and 58n RNAs are 5'-radiolabelled; in C, 74n is 
radiolabelled within the chain; in D and E, the radiolabel in on the 5'-end of the primer used in the reverse transcription reac-
tion (and the bands observed here are thus cDNA transcripts of the 2904n RNA). The lanes U, C, G, and A denote dideoxyse-
quencing reactions. The 58n RNA was partially extended with an extra 3'-nucleotide during T7 transcription (visible as a 
double band in the uncleaved substrate). The proportions of cleavage product are indicated below each gel lane.BMC Molecular Biology 2006, 7:19 http://www.biomedcentral.com/1471-2199/7/19
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1093 data fit much better into an equation describing a
two step exponential decay. This suggests that the
LNAzyme catalyzes a biphasic reaction, which has two kobs
values of 1.37 min-1 and 0.09 min-1.
The two most effective enzymes studied here, Lz1-1093
and Lz2-1093, cleave under a wide range of multiple-turn-
over conditions, and thus function in a truly enzymatic
manner. Comparison of cleavage by the two LNAzymes in
a 20-fold molar excess of the 17n substrate revealed that
Lz1-1093 functions better than Lz2-1093 (Fig. 4C). Cleav-
age by Lz1-1093 under multiple turnover conditions was
investigated further, and the results of time-course experi-
ments for cleavage of the 17n RNA substrate at 5 nM to 1.2
µM are plotted in Fig. 4D. The initial reaction velocities
(v) were measured from the time curves of cleavage at
each substrate concentration; these were used in double
reciprocal plots to estimate Km and the maximal velocity
Vmax. Cleavage of the 17n RNA by Lz1-1093 proceeded
with a Km of 33 nM and Vmax of 1.2 nM min-1; the Lz1-
1093 LNAzyme concentration was 1 nM, giving a turnover
number of 1.2 min-1. The unmodified Dz1-1093 did not
cleave the substrate under these conditions.
Discussion
Hybridization studies on oligonucleotides containing
LNA and α-L-LNA monomers have shown that helical
thermostability is greater than for unmodified nucleic
acid chains [14]. Thus, we surmised that reconstructing
DNAzymes to include LNA and α-L-LNA (forming
LNAzymes) would improve their hybridization proper-
ties, and facilitate cleavage of obstinate RNA substrates.
Consistent with this idea, incorporation of LNA and α-L-
LNA monomers into the enzyme binding arms invariably
improves cleavage performance, and this proved to be the
case irrespective of whether the target was presented in an
Kinetics of cleavage at the 1093-site by LNAzymes Figure 4
Kinetics of cleavage at the 1093-site by LNAzymes. (A) Single turnover cleavage of 17n by Dz1-1093 (circles), Lz1-1093 
(squares) and Lz2-1093 (diamonds). The enzymes are in 5 × excess. (B) Single turnover cleavage of 58n by Dz1-1093 (in 50 × 
excess), Lz2-1093 (in 5 × excess), and Lz2-1093 (in 5 × excess). (C) Multiple turnover cleavage of 17n by Lz1-1093 and Lz2-
1093. (D) Lineweaver-Burk plot showing Lz1-1093 data points obtained over a full range of substrate concentrations (5 nM to 
1.2 µM), and used for determination of Km and Vmax.BMC Molecular Biology 2006, 7:19 http://www.biomedcentral.com/1471-2199/7/19
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unstructured or complexly structured RNA substrate. This
is consistent with other studies of LNA modified
DNAzymes containing blocks of three to five LNA mono-
mers at the ends of the binding arms [10,17]. Better
hybridization of LNAzymes at the RNA target does indeed
play a major role in enhancing cleavage, although other
changes in kinetic parameters probably also contribute to
the greater effectiveness of LNAzymes.
DNAzymes with eight nucleotides per binding arm were
chosen as the starting point for our studies, as this arm
length has been shown to provide a good balance between
substrate recognition and product release [5,20,21]. Previ-
ous observations that only a small fraction of the poten-
tial purine-uridine sites can be cleaved by DNAzymes
[4,5] were reflected in our choice of sites: one site (1093)
is readily cleaved, whereas other two sites (745 and 1096)
are intractable to DNAzymes.
Incorporation of LNA and α-L-LNA monomers into the
binding arms of the DNAzymes improved cleavage at all
three of the sites. Two LNA or α-L-LNA monomers per
eight nucleotide binding arm worked best at the 1093-
site, and increasing this number to three α-L-LNA mono-
mers per binding arm (in Lz5-1093) caused a slight loss of
activity (Fig. 3D), which was particularly noticeable on
the 2904n RNA substrate. Heavily modified arms could
adversely affect parameters such as nonspecific hybridiza-
tion at other sites (especially in large substrates such as
2904n) and release of the product fragments after cleav-
age. However, product release effects would not be
expected to come into play under single-turnover condi-
tions with a large enzyme excess, so the extra modifica-
tions in Lz5-1093 must also interfere with other processes
such as the accessibility of the LNAzyme's binding arms
and/or the folding of its catalytic loop.
Reducing the lengths of the DNAzyme binding arms to
five nucleotides led to loss of activity at the 1093-site
(Dz2-1093). Activity was re-established by incorporating
two  α-L-LNA monomers into each of the arms (Lz4-
1093). An LNAzyme with four nucleotides per binding
arm, two of which were α-L-LNA monomers, also showed
some cleavage activity (Lz3-1093). However, cleavage was
only evident when the accessible 1093-site was displayed
in the least structured substrate (17n) and challenged with
a large molar excess of enzyme. Thus, the structure of the
Lz3-1093 LNAzyme with its tetranucleotide arms is prob-
ably approaching the minimal size that can be expected to
have hydrolytic activity.
LNA and α-L-LNA monomers in a DNA chain have mark-
edly different effects on the helical geometry. Helices con-
taining LNA monomers adopt a local A-form structure
[13], whereas helices containing α-L-LNA tend more
towards the B-form structure [15] with less pronounced
stability [14]. In some cases it appeared more advanta-
geous to use one type of modified monomer – for
instance, at the 745-site, the LNA-enzyme was better than
its α-L-LNA counterpart. At the more amenable 1093-site,
however, no difference was seen in the single turnover
cleavage by comparable LNA and α-L-LNA enzymes (Lz1-
1093 versus Lz2-1093), nor did any differences appear
when the 1093-site accessibility was reduced in the struc-
tured RNA substrates (58n and 2904n). The superior per-
formance of Lz1-1093 compared to Lz2-1093 under
multiple turnover conditions possibly reflects a difference
in hybridisation energy that allows a faster product release
from the α-L-LNA containing Lz1-1093 relative to Lz2-
1093 with LNA monomers.
From the data presented here it can be seen that more
highly structured RNA substrates have a general tendency
to be more resilient to cleavage by nucleic acid enzymes,
and that tighter structure can be counteracted by improv-
ing the hybridization capacity of the enzyme. However,
several exceptions to this rule indicate that factors addi-
tional to substrate structure and enzyme hybridization
play important roles in the cleavage process. For instance,
the 1096-site was more difficult to cleave than the 1093-
site despite being only three nucleotides away and being
displayed in identical substrates. DNAzymes and
LNAzymes designed against the 1096-site had binding
arms that were expected to hybridize at least as strongly as
the enzymes against the 1093-site (Dz3 and Lz6 are calcu-
lated to have Tm values when bound to the RNA that are
4°C higher than Dz1 and Lz2, respectively). Cleavage at
the 1096-site occurs between A and U whereas cleavage at
the 1093-site is between G and U. The identity of the
purine can affect cleavage [22], although this does not
fully explain the large difference observed in Figure 3B.
The kinetic measurements at the 1093-site indicate that
several parameters are involved in determining the rate of
the cleavage reaction. The apparent rate constant kobs for
cleavage of the 17n substrate by the LNAzyme Lz1-1093
was fifty times greater than for the DNAzyme Dz1-1093
under single-turnover conditions with five times excess of
enzyme. Although the excess of Dz1-1093 was probably
not enough to saturate the target, such large differences in
kobs would not be expected if this were the only factor lim-
iting the reaction. Thus, the LNA residues in the binding
arms probably influence parameters other than hybridisa-
tion. One such parameter could involve the folding of the
catalytic loop into an active conformation. The biphasic
reaction of Lz1-1093 in itself suggests the existence of two
conformations of the LNAzyme and/or two conforma-
tions of the LNAzyme/substrate complex.BMC Molecular Biology 2006, 7:19 http://www.biomedcentral.com/1471-2199/7/19
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Conclusion
In conclusion, we concur with Breaker's assertion that
there is potential for improving the catalytic capacity of
10–23-like DNAzymes [23]. We show here that the ability
of 10–23 DNAzymes to hybridize to their RNA substrates
is an important factor in determining whether the target is
cleaved, and in doing so we have improved the hybridiza-
tion potential of several DNAzymes by the incorporation
of locked nucleoside monomers into their binding arms.
However, hybridization capacity is not the only parameter
that can be altered in this way, and the apparent increased
rate constant of the LNAzymes indicate that subsequent
steps such as folding of the enzyme's catalytic loop have
also, if somewhat fortuitously, been enhanced. The Km of
33 nM and the turnover number of 1.2 min-1 measured for
Lz1-1093 show that the binding affinity and kcat of this
LNAzyme are approaching values that are suitable for
practical applications.
Methods
DNAzymes and LNAzymes, 17n RNA, templates and 
primers
DNAzymes composed of unmodified deoxyoligonucle-
otide were obtained commercially. Modified DNAzymes
with α-L-LNA- or LNA thymine monomers in the binding
arms (LNAzymes) were synthesized using published pro-
cedures [11,14].
RNA substrates
The 17n RNA was chemically synthesized (MWG Biotech
AG). The 33n, 58n and 74n RNAs were transcribed using
T7 RNA polymerase (Promega) using buffer conditions
recommended by the supplier, and 1 mM nucleoside tri-
phosphates. The following deoxyoligonucleotides were







AGTCGTATTA. All sequences were hybridized to the com-
plementary deoxyoligonucleotide TAATACGACTCAC-
TATAGG to form the double-stranded T7 promoter.
After transcription, the RNA were extracted and precipi-
tated and the full-length RNA was isolated on a 13% dena-
turing polyacrylamide-7M urea gel. RNAs were eluted
with H2O from gel bands, were extracted with phenol/
chloroform, and were recovered by ethanol precipitation
before being redissolved in H2O. RNA transcripts were
generally 5'-radiolabelled by dephosphorylating using
Shrimp phosphatase (USB) followed by incubation with
T4 polynucleotide kinase (New England Biolab) and [γ-
32P]-ATP. Alternatively, RNAs were labelled in the chain
by inclusion of [α-32P]-CTP in the transcription reaction.
The 2904n RNA (23S rRNA) was extracted from ribos-
omes isolated from Escherichia coli strain IB10 [24] using
previously published methods [25]; the 2904n was not
radiolabelled.
RNA cleavage conditions for single and multiple-turnover 
analyses
The enzymes and RNA substrates were allowed to pre-
equilibrate in the reaction buffer containing 150 mM
NaCl and 50 mM Tris. HCl, pH 7.5 at 37°C for 5 minutes.
The reaction was then initiated by addition of MgCl2 to a
final concentration of 10 mM. In the single-turnover
experiments in Figure 3, the concentration of the substrate
RNA was 1 pmol in a reaction volume of 8 µl (125 nM).
The deoxyribozyme was in excess at either 5 pmol or 50
pmol (625 nM or 6.25 µM) in experiments with the small
RNAs, and at 10 or 20 pmol (1.25/2.5 µM) in experiments
with the 2904n RNA. Single-turnover reactions with min-
imal RNAs were stopped after 1 h by quenching with one-
third volume of ice-cold 90% formamide/20 mM EDTA.
Samples were heated at 80°C for 2 min prior to loading
onto 13% acrylamide polyacrylamide-7M gels.
The 23S rRNA was heated at 70°C for 30 sec and slow
cooled to 37°C to enable refolding to its natural confor-
mation before addition of the DNAzymes. Single-turno-
ver reactions on the 2904n RNA were stopped by the
addition of 20 mM EDTA at 0°C, and analyzed by primer
extension as described below. RNA cleavage was detected
by scanning the gels using phosphor imaging.
In the single-turnover experiments in Figure 4A and 4B,
the concentration of the substrate RNA was 0.8 pmol in a
reaction volume of 8 µl (100 nM) and the deoxyribozyme
was at 4 pmol. In the multiple-turnover experiments
shown in Figure 4C, the enzyme concentration was 30 nM
while the substrate concentration was 0.6 µM. In the mul-
tiple-turnover experiments shown in Figure 4D, the
enzyme concentration was kept constant at 1 nM while
the substrate concentration was varied between 5 nM and
1.2  µM. Enzymes were pre-equilibrated with the 32P-
labelled 17n RNA substrate in 150 mM NaCl, 50 mM Tris.
HCl, pH 7.5 and 0.01% SDS at 50°C for 2 min followed
by a further 2 min at 37°C, before the reaction was initi-
ated by addition of MgCl2 to 10 mM. Sample aliquots
were removed during the reaction and quenched prior to
gel analysis (as described above).
Analysis of cleavage in the 2904n RNA
Due to the large size of this RNA substrate, reverse tran-
scriptase primer extension [26] was used to analyze cleav-
age. Briefly, AMV reverse transcriptase (Finnzymes) was
used to extend two 5'-32P-end-labelled primers, 5'-
CAAGTCATCCGCTAATTTT and 5'-GCCGACTCGAC-BMC Molecular Biology 2006, 7:19 http://www.biomedcentral.com/1471-2199/7/19
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CAGTGAGC, complementary to 23S rRNA nucleotides
750 to 768 and 1099 to 1117, respectively, that are
located immediately downstream from the cleavage sites.
Transcripts stop either at the site of cleavage or immedi-
ately after on uncleaved RNA molecules due to incorpora-
tion of a dideoxynucleotide [27]. Extension products were
analyzed on 13% polyacrylamide/7M urea gels alongside
the sequencing reactions performed on uncleaved RNA
[25].
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